Junkosha honors Creo Medical CTO as the winner of its its Technology Innovator of the Year Awards
Junkosha announced today that it is awarding Creo Medical founder and CTO Chris Hancock with a $25,000 prize as the winner of its inaugural Technology Innovator of the Year Awards.
The U.K.-based company has created an advanced energy multimodality instrument developed for flexible endoscopy. According to Junkosha, Creo Medical’s technology combines the benefits of bipolar RF and super high-frequency microwave energy to provide the ability to dissect, resect, coagulate and inject in a single device — producing results that could reduce cancer recurrence.
“Chris’ breakthrough technology holds the potential to transform the point of treatments for a range of cancers. Overall, Chris’ achievement is one we can use as a yardstick to measure others in future years,” said Joe Rowan, Junkosha’s president and CEO in the U.S. and Europe.
Said Junkosha CEO Mamoru Sogo: “We believe that enabling innovators, like Creo Medical, is central to the philosophy behind the Junkosha brand as we continually look to advance the next generation of technology for a better future. As part of the plans to raise awareness of our new brand internationally, the awards program delivers a tangible commitment to our values.”
Gloss